Point72 Hong Kong LTD Precigen, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $12,861 - $28,295	11,184 New	11,184 $15,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $48,262 - $75,196	-13,672 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $68,223 - $89,551	13,672 New	13,672 $68,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $2,448 - $6,895	-653 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $1,389 - $2,461	-397 Reduced 37.81%	653 $2,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $2,268 - $5,733	1,050 New	1,050 $5,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.